Related Experiment Videos

[A case of suspected liver dysfunction induced by sevoflurane anesthesia]

K Watanabe1, S Hatakenaka, K Ikemune

  • 1Department of Anesthesiology, Ehime Prefecture Imabari Hospital.

Masui. the Japanese Journal of Anesthesiology
|June 1, 1993
PubMed

Insights

This case study highlights potential toxic liver dysfunction in an infant following sevoflurane anesthesia. Elevated liver enzymes normalized within two months, suggesting a non-allergic, sevoflurane-induced hepatotoxicity.

Area of Science:

  • Anesthesiology
  • Pediatric Hepatology
  • Toxicology

Background:

  • Sevoflurane is a widely used inhalational anesthetic in pediatric surgery.
  • Liver dysfunction is a rare but serious complication associated with general anesthesia.
  • Distinguishing between allergic and toxic reactions to anesthetic agents is crucial for patient management.

Observation:

  • A 30-day-old male infant developed symptoms of liver dysfunction, including vomiting and anorexia, two days post-inguinal herniorrhaphy under sevoflurane anesthesia.
  • Significant elevations in liver enzymes (GOT, GPT, LDH) were observed, peaking 12-16 days after surgery.
  • Viral hepatitis markers, blood transfusions, and antibiotic use were ruled out as causes.

Findings:

  • The infant's clinical symptoms and laboratory values indicating liver dysfunction gradually resolved within two months.
  • A lymphocyte stimulation test for sevoflurane allergy was negative.
  • The pattern of liver enzyme elevation and clinical course suggested a toxic, rather than allergic, reaction to sevoflurane.

Implications:

  • This case suggests that sevoflurane can cause direct toxic liver injury in infants, independent of an allergic mechanism.
  • Further investigation into the mechanisms of sevoflurane-induced hepatotoxicity is warranted.
  • Clinicians should consider sevoflurane toxicity in the differential diagnosis of unexplained liver dysfunction in pediatric patients post-anesthesia.

Related Concept Videos